A Phase II Study of Chemoimmunotherapy for Patients With Potentially Platinum Sensitive Müllerian (Epithelial Ovarian, Peritoneal, or Fallopian Tube) Carcinomas.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2012
At a glance
- Drugs Carboplatin; Interferon gamma; Sargramostim
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Aug 2009 Actual end date (1 Jan 2009) added as reported by ClinicalTrials.gov.
- 21 Aug 2009 Actual patient number (59) added as reported by ClinicalTrials.gov.